Immunology:
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • Humira logo
      Humira logo
      About Humira
      Presentation & Dosing
      Pen Design
      Services
      Resources

      At AbbVie, patient care doesn’t stop at the prescription

      AbbVie has a legacy of partnership and commitment to research and development in rheumatology to advance the standard of care. We aspire to tackle global challenges in rheumatology and shape the future of disease management.

      Beyond the consult
      Compassionate Access
      Compassionate Access Program

      Request compassionate supply of AbbVie medicines

      ACCESS NOW ➜

      AbbVie Care
      Patient Support

      Services and tools to support your HUMIRA & Skyrizi patients patients

      READ MORE ➜

      Destination Pharmacy
      Destination Pharmacy

      Selected pharmacies with services to better assist your patients

      ACCESS NOW ➜

      Contact a representative
      Submit a report
      submit a report or request

      Submit a report or request

      Please select the action you wish to take.

      Request a product sample

      REQUEST NOW ➜

      Report a product quality complaint

      REPORT NOW ➜

      Report an adverse event

      REPORT NOW ➜

      More for you

      About HUMIRA
      ABOUT HUMIRA
      About RINVOQ
      ABOUT RINVOQ
      About Skyrizi
      ABOUT SKYRIZI

      PBS Information

      HUMIRA: Authority required. Refer to PBS Schedule for full authority information. This product is not listed on the PBS for the treatment of enthesitis-related arthritis or paediatric psoriasis.

      Please review the full Product Information (PI) before prescribing, available below.

      HUMIRA PI

      AU-HUM-220104. August 2024